EIN 81-0640775

Multiple Myeloma Research Consortium

IRS 501(c) type
501(c)(3)
Num. employees
4
Year formed
2003
Most recent tax filings
2014-12
Notice
This nonprofit is terminated or no longer active
Multiple Myeloma Research Consortium is likely terminated and or no longer active. Either the organization marked in their most recent Form 990 that they have closed down, or they haven't filed a Form 990 in many years and appear to no longer be active.
Description
To champion collaboration with and integration across academia and industry and to focus on speed and innovation to bring the most promising multiple myeloma treatments to patients faster. To champion collaboration with and integregation across academ...
Also known as...
MMRC Inc

Program areas at Multiple Myeloma Research Consortium

Site investment grants: the purpose of the site investment grant is to assist in funding a multiple myeloma program coordinator in continuing to fulfill its obligations as a consortium member which are: 1) participating in clinical trials conducted within the mmrc clinical trial network, 2) providing patient specimens to the mmrc tissue bank, and 3) engaging with the mmrc leadership team to advance new treatment options for patients with multiple myeloma.
Clinical trials:these costs cover mmrc site expenses to conduct the various clinical studies that the consortium members undertake each year. These include costs for our contract research organization (cro) which is responsible for oversight of our clinical trial processes including site training, study start up, regulatory compliance, data collection, monitoring and reporting, and project management. The cro also organizes safety reviews and maintains metrics to ensure study meets expected timeline. Also included in these site expenses are payments for tests, procedures, and staff fees in support of patients enrolled on our clinical trials.
Mmrc tissue bank:the mmrc tissue bank is a centrally located, standardized tissue bank of highly annotated bone marrow and peripheral blood samples from myeloma patients and patients with myeloma related disorders. Housed at the mayo clinic, in scottsdale, Arizona, the tissue bank is the only resource of its kind that accrues samples provided by mmrc institutions under good laboratory practice (glp) standard procedures with the corresponding clinical data. The budget granted to the mayo scottsdale for the tissue bank enables the tissue to be uniformly processed and stored in adherence with glp standards and under the governance of more than 80 standard operating procedures. The mmrc has also established a quality assurance unit that performs regular internal reviews and issues quarterly quality assurance reports. The payments to mayo scottsdale reflect the standard costs to support the full time employees needed to perform the processing activities as well as variable charges depending on the actual number of samples sent to bank to be processed. The mmrc has a specifically designed tissue tracking system that collects information on the tissue samples with respect to processing and storage as well as comprehensive clinical data and medical histories on the de-identified patients who have provided samples. All data in the mmrc tissue tracking system is consistently collected and maintained using standardized processes that ensure data integrity. Furthermore, the data is collected and managed in a manner consistent with all regulatory requirements, including those of the u.s. food and drug administration (fda), the health insurance portability and accountability act of 1996 (hipaa) and is compliant with other federal regulations. The costs associated with the tissue tracking system are distinct from the mmrc tissue bank and include a hosting service for the database, it support, and maintenance contracts for the software that supports the tissue tracking system. This specifically designed tissue tracking system enables scientists to perform customized and pre-configured queries on highly-annotated tissue samples, comprehensive clinical data and medical histories; functions that are essential in advancing the mmrc's pre-clinical projects, clinical trials, and correlative studies.

Form 990s for Multiple Myeloma Research Consortium

Fiscal year endingDate received by IRSFormPDF link
2014-122015-11-17990View PDF
2013-122014-10-22990View PDF
2012-122014-01-09990View PDF
2011-122012-11-02990View PDF
2009-122011-02-07990View PDF

Financials for Multiple Myeloma Research Consortium

RevenuesFYE 12/2013
Total grants, contributions, etc.$4,016,000
Program services$0
Investment income and dividends$766
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$0
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$902
Total revenues$4,017,668

Personnel at Multiple Myeloma Research Consortium

NameTitleCompensation
Kathy GiustiFounder / President$0
James GrazickTreasurer and Director of Fina$0
Walter CaponePresident$0
 Subscribe to viewChief Marketing Officer$71,616
 Subscribe to viewSecretary and in House Council$0

Organizations like Multiple Myeloma Research Consortium

OrganizationLocationRevenue
Oncology Nursing FoundationPittsburgh, PA$1,745,128
Cardiovascular Research Foundation of Southern CaliforniaBeverly Hills, CA$1,389,213
Diabetes Research and Wellness FoundationWashington, DC$2,635,867
The Naspghan FoundationAmbler, PA$1,594,603
Translational Research InstituteAustin, TX$1,996,070
The Bluefield Project to Cure Frontotemporal DementiaSan Francisco, CA$1,259,963
Jeffrey Modell Foundation (JMF)New York, NY$7,432,855
PSC Partners Seeking A CureGreenwood Village, CO$1,023,196
Hearing Health FoundationNew York, NY$2,628,977
Stanley Medical Research Institute (SMRI)Kensington, MD$8,482,259
Cincinnati Sight Restoration FoundationCincinnati, OH$2,178,503
Hydrocephalus Association (HA)Bethesda, MD$4,569,449
MDS Foundation / The Myelodysplastic Syndromes FoundationYardville, NJ$1,531,833
Hereditary Disease FoundationNew York, NY$2,691,357
American-Italian Cancer Foundation (AICF)New York, NY$2,213,046
The Adenoid Cystic Carcinoma Research FoundationNeedham, MA$2,103,655
Human Vaccines ProjectNew York, NY$5,216,398
Open Medicine FoundationAgoura Hills, CA$4,286,613
Foundation for Sarcoidosis Research (FSR)Chicago, IL$4,058,860
Parent Project Muscular Dystrophy (PPMD)Hackensack, NJ$9,071,159
Foundation for Prader Willi Research (FPWR)Walnut, CA$4,152,623
Diabetes Research Institute Foundation (DRIF)Hollywood, FL$8,922,536
Israel Cancer Research FundNew York, NY$3,897,018
Progeria Research Foundation (PRF)Peabody, MA$2,884,717
Center for Infectious Disease ResearchMercer Island, WA$9,034,127
Nonprofit Types
Issues
Characteristics
Key performance indicators
Total revenues
$4,017,668
2013
Yearly growth
-12.2%
% of revenues
n/a
Total expenses
$4,016,445
2013
Yearly growth
-11.5%
% of expenses
n/a
Total assets
$3,517,392
2013
Yearly growth
-10.6%
% of assets
n/a
Num. employees
4
2013
Yearly growth
-20%
% of total
n/a
General information
Address
383 Main Avenue 5TH Floor
Norwalk, CT 06851
Metro area
Bridgeport-Stamford-Norwalk, CT
Phone
(203) 972-1250
IRS details
EIN
81-0640775
Fiscal year end
December
Taxreturn type
Form 990
Year formed
2003
Eligible to receive tax-deductible contributions (Pub 78)
No
Categorization
NTEE code, primary
H50: Nerve, Muscle, and Bone Research
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Independent